Congqing Jiang

13PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 08, 2026
CDK10 suppresses nucleic acid sensors-mediated antitumor immunity.

Gaoshan Xu, Fusheng Guo, Chuan He

|Sep 05, 2025
ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion.

Jianhong Zhao, Baoxiang Chen, Yanrong Deng

|Apr 14, 2025
Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer.

Jinwen Yin, Yu Shao, Fengxing Huang

|Feb 07, 2025
Risk factors of symptomatic internal hernias after left hemicolectomy: a multicenter retrospective study.

Siyuan Yin, Haibo Li, Jun Xu

|May 21, 2024
Metabolic Recoding of NSUN2-Mediated m5C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m5C-ENO1 Positive Feedback Loop.

Baoxiang Chen, Yanrong Deng, Yuntian Hong

|Dec 08, 2023
m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation.

Baoxiang Chen, Yuntian Hong, Xiang Zhai

Pageof 3

Frequent Collaborators

7 joint publications

Xianghai Ren

4 joint publications

Yuntian Hong

2 joint publications

Jinfang Zhang

1 joint publications

Changlei Xi